New patent for the Aerie Pharms ROCKLATAN drug – DrugPatentWatch
Annual Drug Patent Expiration for ROCKLATAN
Rocklatan is a drug marketed by Aerie Pharms Inc and included in one NDA. It is available from a single supplier. There are fifteen patents protecting this drug.
ROCKLATAN drug price trends.
This drug has sixty patent family members in eleven countries.
The generic ingredient in ROCKLATAN is latanoprost; netarsudil dimesylate. One registered supplier for this compound. Additional details are available on latanoprost; netarsudil dimesylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for Aerie Pharms’ ROCKLATAN drug
